Home » ASCO 2018 Multiple Myeloma
Education Session Presentations

ASCO 2018 Multiple Myeloma
Education Session Presentations

There are four multiple myeloma-related education sessions at the American Society of Clinical Oncology (ASCO) 2018 annual meeting.

Two of those sessions will take place on Saturday, June 2, and one each will be held on Friday, June 1, and Sunday, June 3.

In the education session in­­for­ma­tion below, presentations are listed in the order they will be given within their session. Presentation titles are accompanied by the name of the presenter and, when available, a link to the relevant abstract and accompanying article in the 2018 ASCO Education Book (PDF).

Links to PDF files containing the slides for each presentation will be added to this list as those files are made available to The Beacon courtesy of the ASCO presenters.

The Beacon also has similar lists of ASCO 2018 multiple myeloma-related oral presentations, poster presentations, and e-abstracts, as well as news articles about multiple myeloma at the ASCO 2018 meeting.


Session Precision Medicine in Myeloma: Are We There Yet?
Type Education Session (Session Info From ASCO)
Time Friday, June 1, 1:00 PM - 2:15 PM
Location E450
Chair Craig Cole, MD

#1 - Risk Stratification and Targets in MM: From Genomics to the Bedside

Presented by: Herve Avet-Loiseau, MD, PhD; related abstract.

#2 - Should High-Risk Patients Be Treated Differently?

Presented by: Craig Cole, MD

#3 - CAR-T and Cellular Therapy in Myeloma

Presented by: Adam D. Cohen, MD; related abstract.


Session Bones in Myeloma: Imaging and Therapy
Type Education Session
Time Saturday, June 2, 8:00 AM - 9:15 AM
Location E450

#1 - Is Skeletal Survey Dead in Myeloma? What Imaging to Use and When?

Presented by: Elena Zamagni, MD, PhD

#2 - Practical Use of Imaging From MGUS to Myeloma

Presented by: Ravi Vij, MD

#3 - Optimal Use of Bisphosphonates and Other Agents in Bone Disease in Multiple Myeloma

Presented by: G. David Roodman, MD, PhD


Session Practical Considerations for Antibodies in Myeloma
Type Education Session
Time Saturday, June 2, 1:15 PM - 2:30 PM
Location E450

#1 - Debate: Should Everyone Receive Monoclonal Antibodies in First Relapse? Yes

Presented by: Jacob Laubach, MD

#2 - Debate: Should Everyone Receive Monoclonal Antibodies at First Relapse? No

Presented by: Joseph Mikhael, MD

#3 - What Do You Do When Monoclonal Antibodies Fail?

Presented by: Niels Van De Donk

#4 - Future Monoclonal Antibodies: BCMA and Beyond

Presented by: Faith Davies, MD, MRCP, MRCPATH, FRCPath


Session Global Myeloma, Health Disparities, and the Cost of Drugs
Type Education Session
Time Sunday, June 3, 4:45 PM - 6:00 PM
Location E450

#1 - Myeloma Outcomes and Disparities in African Americans

Presented by: Timothy Rebbeck, PhD

#2 - Global Approaches in Myeloma: Critical Trials That May Change Practice

Presented by: Philippe Moreau, MD

#3 - Debate: Value and Cost of Myeloma Therapy—We Cannot Afford It

Presented by: S. Vincent Rajkumar, MD

#4 - Debate: Debate: Value and Cost of Myeloma Therapy—We Can Afford It

Presented by: Rafael Fonseca, MD